Progress report: A randomized multicenter European study comparing adjuvant radiotherapy, 6-Mo chemotherapy and combination therapy vs no- adjuvant treatment in resectable pancreatic cancer (ESPAC-1)

International Journal of Pancreatology

Volumn 21, Issue 2, 1997, Pages 97-104

  Neoptolemos, John P ^a,f   Baker, Pat ^a   Beger, Hans ^b   Link, Karl ^b   Pederzoli, Paolo ^c   Bassi, Claudio ^c   Dervenis, Christos ^d   Friess, Helmut ^e   Büchler, Markus ^e  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF VERONA   (Italy)

^d AGIA OLGA HOSPITAL   (Greece)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adjuvant therapy; ESPAC; Multicenter randomized trial; Resectable pancreatic cancer

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; EUROPE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT;

EID: 0030926622     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, eds., Cancer Incidence in Five Continents. vol. VI, International Agency for Research on Cancer 1992, Lyon (IARC Scientific Publications No. 120).
2. Fernandez E, Lavecchia C, Porta M, Negri M, Lucchini F, Levi F. Trends in pancreatic cancer mortality in Europe, 1955-89. Int J Cancer 1994; 57: 786-792.
3. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111-115.
4. Gudjonson B. Cancer of the pancreas. Fifty years of surgery. Cancer 1987; 9: 2284-2303.
5. Office of Population Censuses and Surveys. Mortality Statistics : Cause : Review of the Registrar General on deaths by cause, sex and age, in England and Wales. Series DH2. No. 19. London, HMSO 1992.
6. Carter DC. Cancer of the pancreas. Gut 1990; 31: 494-496.
7. Russell RCG. Surgical resection for cancer of the pancreas. Clin Gastroenterol 1990; 4: 889-916.
8. Beger HG, Link KH, Poch B, Gansauge F. Pancreatic cancer - recent progress in diagnosis and treatment, in Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Science, Oxford, 1996: 227-235.
9. The Cancer Registry ofNorway. Survival of cancer patients. Cases diagnosed in Norway 1968-75. Oslo: The Cancer Registry of Norway 1980.
10. Trede M, Schwall G, Saeger H-D. Survival after pancreatoduodenectomy. 188 resections without an operative mortality. Ann Surg 1990; 211: 447-458.
11. Gall FP, Kessler N, Hermanek P. Surgical treatment of ductal pancreatic carcinoma, Eur J Surg Oncol 1991; 17: 173-181.
12. Kanyu F, Suzuki M, Imaizumi T. Whipple operation for pancreatic carcinoma: Japanese experience, in Standards in Pancreatic Surgery. Beger HG, Büchler M, Malfertheiner P, eds., Springer-Verlag, Berlin, 1993: 6467-6453.
13. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165: 68-72.
14. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994; 81: 1190-1193.
15. Allema JH, Reinders ME, Van Gulik TM, Koelemay JW, Ban Leeuwen DJ, De Wit LT, Gouma DJ, Obertop H. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995; 75: 2069-2076.
16. Nitecki SS, Sarr MG, Colby TV, Van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221: 59-66.
17. Yeo CJ, Cameron JL, Allemoe KD, Sitzman JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221: 721-733.
18. UK Pancreatic Cancer Group (UKPACA). Resection for pancreatic and periampullary tumours in 820 patients. UK survey of specialist units. Int J Pancreatol 1996, 19: 243 (abstract).
19. Neoptolemos JP, Lemoine N, Ching CH, Rhodes JM. Cancer of the pancreas and ampulla of Vater, in Premalignancy and Early Cancer in General Surgery. Fielding J, Allum W, eds., Oxford University Press, Oxford, 1996 (in press).
20. Warshaw AL, Fernandez-Del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465.
21. Wagner M, Friess H, Büchler MW. Conservative versus radical resections of the pancreas, in Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Scientific Publications, Oxford, 1996: 248-270.
22. Pedrazzoli S, Di Carlo V, Dionigi R, Michelassi F, Mosca F, Pederzoli P. Preliminary results of traditional and extended lymphadenectomy in resection of pancreatic head cancer. Digestion 1993; 54: 299 (abstract).
23. Neoptolemos JP, Bramhall S, Kerr DJ. Principles of adjuvant treatment in pancreatic cancer, in Cancer of the Pancreas. Beger H, Büchler M, Schoenberg M, eds., Universitatsverlag Ulm GmbH, Ulm, Germany, 1996; 479-487.
24. Ishikawa D, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T. Practical usefulness of lymphatic and coMective tissue in the clearance for the carcinoma of the pancreas head. Ann Surg 1988; 208: 215-220.
25. Manabe T, Oshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T. Radical pancreatectomy for ductal carcinoma of the head of the pancreas. Cancer 1989; 64: 1132-1137.
26. Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar A, Fenoglio CJ, Lee JE, Evans DB. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric - portal vein confluence. Ann Surg 1996; 223: 154-162.
27. Bramhall SR, Neoptolemos JP. Adjuvant treatment of pancreatic cancer, in Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Scientific Publications, Oxford, 1996: 288-307.
28. Garton GR, Gunderson LL, Nagorney DM, Donohue JH, Martin JK, Mcllrath DC, Cha SS. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiation Oncology Biol Phys 1993; 27: 1153-1157.
29. Hoffman JP, Weese JL, Solin LJ, Engstrom P, Agarwal P, Barber LW, Guttman MC, Utwin S, Salazar H, Eisenberg BL. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 1995; 169: 71-77.
30. Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Iwanaga T, Matayoshi Y, Inoue T. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg 1994; 129: 1075-1080.
31. Rich TA, Evans DB. Preoperative combined modality therapy for pancreatic cancer. World J Surg 1995; 19: 264-269.
32. Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans BD. Preoperative chemoradiation, pancreaticoduodenectomy and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996; 171: 118-125.
33. Kalser MH, Ellengerg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903.
34. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater. Results of a controlled, prospective, randomized multicenter study. Eur J Cancer 1993; 29: 698-703.
35. Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 reds) radiation alone, moderate dose radiation (4000 reds) and high dose radiation and 5-Fluorouracil. Cancer 1981; 48: 1705-1710.
36. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59: 2006-2010.
37. United Kingdom Pancreatic Cancer Group (UKPACA). Adjuvant therapy following resection of pancreatic cancer. Gut 1993; 34: 1290 (Abstract).
38. Arbuck SG. Chemotherapy for pancreatic cancer. Clin Gastroenterol 1990; 4: 953-968.
39. Cullinan S, Moertel CG, Eieand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetier LK, Barlow JF. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluation of the Mallinson regimen and combined 5-Fluorouracil, doxorubicin and cisplatin. Cancer 1990; 65: 2207-2212.
40. Willett CG, Lewandrowski K, Warshaw AL, Efird J. Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993, 217: 144-148.
41. Schutte M, Kern SE. The molecular genetics of pancreatic adenocarcinoma, Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Scientific Publications, Oxford, 1996: 115-132.
42. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA, Green MR, Tarassoff PG, Brown TD, Casper EJ, Storniolo A-M, Von Hoff DD. A phase II trial of gemcitabine in patients with 5-DU refractory pancreas cancer. Ann Oncology 1996; 7: 347-353.
43. Moore M, Andersen J, Burris H, Tarassoff M, Green E, Casper R, Portenoy R, Modiano M, Cripps C, Nelson R, Storniolo A, Von Hoff D. A randomized trial of gemcitabine (GEM) versus 5-FU as first-line therapy in advanced pancreatic cancer. Proc ASCO 1995; 14: 199 (abstract No. 473).
44. Bramhall S, Stamp GHH, Lemoine NR, Neoptolemos JP. The matrix metalloproteinases and their inhibitors in pancreatic cancer, in Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Scientific Publications, Oxford, 1996: 68-91.
45. Evans JD, Bramhall SR, Stark A, Hinley H, Porter C, Osborne L, Daniel F, Carmichael J, Imrie C, Johnson CD, Neoptolemos JP. A phase II trial of Marimastat (BB-2516) in advanced pancreatic cancer. Int J Pancreatol 1996; 19: 218 (abstract).
46. Lemoine NR. Strategies for genetic intervention in pancreatic cancer, in Pancreatic Cancer: Molecular and Clinical Advances. Neoptolemos JP, Lemoine NR, eds., Blackwell Scientific Publications, Oxford, 1996: 181-193.
47. Green NK, Youngs DJ, Searle PF, Young LS, Kerr DJ, Neoptolemos JP. Gene therapy for pancreatic cancer. Bystander killing in pancreatic cancer cells using the nitroreductase/CB 1954 approach. Int J Pancreatol 1996; 19: 226 (abstract).